The SimplySure PT-INR (Prothrombin Time-International Normalized Ratio) Test for whole blood coagulation leverages a unique, patented technology that provides a visual quantitative reading directly on the test strip without the need of an expensive external test instrument.
The first quantitative, “un-plugged” whole blood coagulation test for PT/INR!
No capital expenditure, No instrument needed
Uses a few drops of whole blood
Point-of-Care convenience – Healthcare providers can test patients or have patients test themselves at home.
Fast Results – typically in less than three minutes.
Easy to use – runs like a glucose test and reads like a thermometer.
Compact & Disposable device
Patent protected (US patent 6,759,009, issued July 2004)
SimplySure PT-INR does not require complex and costly instrumentation for testing.
All competition requires upfront instrument/device cost >$900.
Simplicity and cost effectiveness of SimplySure PT-INR enables easy physician office or self-testing without need for additional infrastructure or patient assistance.
Disposable test design facilitates INR monitoring at any time any place.
Developing innovative tests for underserved markets